Search for: "John Abbott"
Results 481 - 500
of 656
Sorted by Relevance
|
Sort by Date
1 Aug 2011, 9:40 am
"I'm not on the commission, so I don't know what it will do," he said, adding that, given Abbott's ruling, moving forward with the investigation "would really threaten the rule of law. [read post]
14 Aug 2012, 6:30 am
"Expert makeover" was how News Limited’s cartoonist Jon Kudelka described it, drawing Julia Gillard slowly morphing into John Howard. [read post]
26 Sep 2016, 4:43 am
Abbott that states can draw legislative districts based on total population to mean that prisoners “can be counted in population totals for determining a voting district, even though they can’t cast ballots in the place where they’re being held” “shows how delicate the theory of virtual representation used in the Evenwel case really is. [read post]
1 Oct 2010, 2:59 am
MansfieldPhone: 805-922-0055Fax: 805-922-8462E-mail: brian@primuslabs.comScope: crops and handlingAccredited: 1/22/06 Quality Assurance International9191 Towne Centre Dr., Suite 510San Diego, CA 92122Contact: Maria DeVincenzoPhone: 858-792-3531Fax: 734-827-6177E-mail: qai@qai-inc.comScope: crop, livestock, wild crop, handlingAccredited: 4/29/02 Yolo County Department of Agriculture70 Cottonwood St.Woodland, CA 95695Contact: John YoungPhone: 530-666-8141Fax: 530-662-6094E-mail:… [read post]
3 Dec 2023, 6:18 am
Prior to joining Horizon, Patrick served at Abbott Labs as the DVP Global Privacy and at Gilead Sciences as the Enterprise Privacy Officer. [read post]
11 Jun 2021, 1:29 pm
Senator John Cornyn, House members in the Region, and the Greater Houston Partnership. [read post]
27 Oct 2010, 3:38 am
Abbott (EPLAW) Lunesta (Eszopiclone) – US: Cobalt Pharmaceuticals and Sepracor settle Lunesta patent litigation (Patent Docs) Mirapex (Pramipexole) – US: Mylan receives approval for generic version of Mirapex tablets (SmartBrief) Oracea (Doxycyline) – US: Mylan seeks declaratory judgment of non-infringement and invalidity based on ANDA filing: Mylan v Galderma (Patent Docs) Perlane, Restylane (Hyaluronic acid) – US: Genzyme files patent infringement complaint against… [read post]
28 Feb 2018, 3:23 am
John S. [read post]
28 Feb 2018, 3:23 am
John S. [read post]
7 Nov 2011, 8:31 pm
John Carona. [read post]
4 Dec 2007, 5:55 pm
John Cos., 469 F.3d 1361, 1365 (Fed. [read post]
25 Nov 2009, 8:35 am
Abbott (Edward Ball Eminent Scholar Professor of International Law, Florida State University College of Law) and Graham Dukes (External Professor of Drug Policy Studies, Institute of General Practice and Community Health, University of Oslo, Norway). [read post]
13 May 2016, 8:21 am
In Illinois, five “John Does” and “Jane Does” recently filed a lawsuit in U.S. [read post]
31 Oct 2012, 4:28 am
Public Interest Research Group and the Universities Allied for Essential Medicines -- that the National Institutes of Health (NIH) grant Bayh-Dole Act march-in rights for the patents held by Abbott Laboratories relevant to the manufacture and sale of anti-retroviral drug ritonavir, which the KEI media release describes as "a federally funded invention that is much more expensive in the United States than in Canada, Europe or other high-income countries". [read post]
31 May 2018, 9:45 pm
Yes and no, wrote Ai Deng, lecturer with the Advanced Academic Programs at Johns Hopkins University and principal at Bates White Economic Consulting, in a draft paper. [read post]
9 Apr 2009, 6:10 am
Shell's Response Shell Canada's John Abbott, Executive Vice President, Oil Sands provided the following statement in response to the allegations: "We understand and share the concerns of stakeholders on greenhouse gas emissions from oil sands. [read post]
16 Aug 2023, 1:26 pm
Until recently, Professor Kumar held the John Mixon Chair in Law at the University of Houston Law Center. [read post]
28 Feb 2018, 3:23 am
John S. [read post]
24 Aug 2012, 4:57 pm
John Deere Co., 383 U.S. 1, 17 (1966). [read post]
4 Feb 2015, 1:52 pm
In In re Cuozzo Speed Technologies, a split CAFC panel observedContrary to Cuozzo’s contention, we hold that we lackjurisdiction to review the PTO’s decision to institute IPR.We affirm the Board’s final determination, finding noerror in the Board’s claim construction under the broadestreasonable interpretation standard, the Board’s obviousnessdetermination, and the Board’s denial of Cuozzo’smotion to amend.The legal matter involved an inter partes review… [read post]
